MariMed (MRMD) grants CFO 153,125 RSUs vesting through 2027

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

MariMed Inc. Chief Financial Officer Mario Pinho received a grant of 153,125 Restricted Stock Units (RSUs) on April 15, 2026. The RSUs convert into common stock on a one-for-one basis. They vest in four equal installments on July 15, 2026, October 15, 2026, January 15, 2027 and April 15, 2027.

Following these transactions, Pinho directly holds 277,485 shares of MariMed common stock, alongside the new RSU award, reflecting his updated equity-based compensation and ownership position.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Pinho Mario

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units (RSU)	153,125	$0.00	--
holding	Common stock	--	--	--

Holdings After Transaction: Restricted Stock Units (RSU) — 153,125 shares (Direct); Common stock — 277,485 shares (Direct)

Footnotes (1)

RSUs convert to shares of common stock on a one-for-one basis. The RSUs will vest in four equal installments on each of July 15, 2026, October 15, 2026, January 15, 2027 and April 15, 2027.

Key Figures

RSU grant: 153,125 units Common stock holdings: 277,485 shares Vesting installments: 4 equal installments +1 more

4 metrics

RSU grant 153,125 units Restricted Stock Units awarded on April 15, 2026

Common stock holdings 277,485 shares Direct ownership after April 15, 2026 transactions

Vesting installments 4 equal installments On July 15, 2026; October 15, 2026; January 15, 2027; April 15, 2027

RSU conversion ratio 1 RSU : 1 share RSUs convert to common stock on a one-for-one basis

Key Terms

Restricted Stock Units (RSU), one-for-one basis, vest, Common Stock, par value $.001 per share

4 terms

Restricted Stock Units (RSU) financial

"security_title: "Restricted Stock Units (RSU)""

one-for-one basis financial

"RSUs convert to shares of common stock on a one-for-one basis."

vest financial

"The RSUs will vest in four equal installments on each of the specified dates."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Form 4 Insider Transactions: What Each Field Means →

04/17/2026 - 05:18 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pinho Mario

(Last)

(First)

(Middle)

C/O MARIMED INC.

10 OCEANA WAY

(Street)

NORWOOD

MASSACHUSETTS

02062

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common stock								277,485	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units (RSU)	⁽¹⁾	04/15/2026		A			153,125	⁽²⁾	⁽²⁾	Common Stock, par value $.001 per share	153,125	$0	153,125	D

Explanation of Responses:

1. RSUs convert to shares of common stock on a one-for-one basis.

2. The RSUs will vest in four equal installments on each of July 15, 2026, October 15, 2026, January 15, 2027 and April 15, 2027.

Remarks:

The RSUs were granted in lieu of cash payment of a portion of the Reporting Person's annual bonus for the fiscal year ended December 31, 2025.

	/s/ Mario Pinho	04/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did MariMed (MRMD) report for CFO Mario Pinho?

MariMed reported that CFO Mario Pinho received a grant of 153,125 Restricted Stock Units (RSUs). The award was recorded on April 15, 2026 and represents equity-based compensation that can convert into common stock, subject to the specified vesting schedule.

How many RSUs did MariMed (MRMD) grant to its CFO and on what terms?

MariMed granted its CFO 153,125 Restricted Stock Units (RSUs) at a stated price of $0.00 per unit. Each RSU converts into one share of MariMed common stock, providing potential future ownership as the units vest over time according to the schedule disclosed.

What is the vesting schedule for the 153,125 RSUs granted by MariMed (MRMD)?

The 153,125 RSUs will vest in four equal installments. Vesting dates are July 15, 2026, October 15, 2026, January 15, 2027, and April 15, 2027, gradually delivering common shares to the CFO as each installment becomes fully vested.

How many MariMed (MRMD) common shares does the CFO hold after this Form 4?

After the reported transactions, the CFO directly holds 277,485 shares of MariMed common stock. This figure reflects his updated direct ownership position as of April 15, 2026, in addition to the separate 153,125 RSUs that may convert into shares over time.

What does it mean that MariMed (MRMD) RSUs convert on a one-for-one basis?

A one-for-one basis means each Restricted Stock Unit converts into one share of MariMed common stock. When the RSUs vest on their scheduled dates, the CFO is entitled to receive the equivalent number of common shares for each vested unit, increasing his shareholdings.

Does the MariMed (MRMD) Form 4 show any stock sales by the CFO?

The Form 4 shows a grant of 153,125 Restricted Stock Units to the CFO and an updated common stock holding of 277,485 shares. It does not report any open-market sales or disposals; the primary transaction is an equity award acquisition.